in111-octreoscan Report issue

Biologics Peptide Imaging Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now
An octreotide scan is a type of SPECT scintigraphy used to find carcinoid, pancreatic neuroendocrine tumors, and to localize sarcoidosis. It is also called somatostatin receptor scintigraphy (SRS). Octreotide, a drug similar to somatostatin, is radiolabeled with indium-111, and is injected into a vein and travels through the bloodstream. The radioactive octreotide attaches to tumor cells that have receptors for somatostatin. A gamma camera detects the radioactive octreotide, and makes pictures showing where the tumor cells are in the body, typically by a SPECT technique. A technetium-99m based radiopharmaceutical kit is also available.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: No
  • Imaging: 111-indium
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

111-indium-pentetreotide | 111 in -pentetreotide | 111in-pentetreotide | dtpa-sms | in111-octreoscan | in-111 pentetreotide | in111 pentetreotide | in111-pentetreotide | indium (111in) pentetreotide | indium in 111 pentetreotide | indium in-111 pentetreotide | indium in-111 pentetreotide kit | indium in 111 pentreotide | indium ln-111 pentetreotide | indium pentetreotide | indium-pentetreotide | mp-1727 | octreoscan | octreoscan 111 | sdz-215811s

Organizations (17)

Research & Development (16)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (1)


 

Diagnostic Imaging (approved 1994)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Adrenocorticotropic Hormone (Phase 2)

Cushing Syndrome (Phase 2)

Metabolic Diseases (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 4)

Neuroendocrine Tumors (Phase 3)

Pancreatic Neoplasms (Phase 1/Phase 2)

Sepsis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial Organizations: 16

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue